PegenzileukincemiplimabpembrolizumabMMcutaneous squamous cell carcinomaCSCC
…ombinations in patients with MM (Cohort A) and CSCC (Cohort B). Pegenzileukin was given at two dose levels (16 µg/kg: Cohort A1 and B1 and 24…
2articles mentioning drugs
8drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: Pegenzileukin ×
Pegenzileukin
This drug is selected. Its supporting articles are shown below.
Articles mentioning Pegenzileukin
2 articles · page 1 of 1pegenzileukinmonoclonal antibodieshuman IL-15hematological malignanciesaccredited facility
…γ receptors. This combination of NK cell adoptive transfer with pegenzileukin treatment resulted in remarkable enhancement of NK cell persist…